Cargando…

Current Knowledge on Pancreatic Cancer

Pancreatic cancer is the fourth leading cause of cancer death with a median survival of 6 months and a dismal 5-year survival rate of 3–5%. The development and progression of pancreatic cancer are caused by the activation of oncogenes, the inactivation of tumor suppressor genes, and the deregulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iovanna, Juan, Mallmann, Maria Cecilia, Gonçalves, Anthony, Turrini, Olivier, Dagorn, Jean-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356035/ https://www.ncbi.nlm.nih.gov/pubmed/22655256 http://dx.doi.org/10.3389/fonc.2012.00006

Ejemplares similares

The WSB1 Gene Is Involved in Pancreatic Cancer Progression
por: Archange, Cendrine, et al.
Publicado: (2008)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Autophagy Induced during Pancreatitis Promotes KRAS-Dependent Transformation in the Pancreas
por: Iovanna, Juan L.
Publicado: (2016)

S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives
por: Wu, Yu, et al.
Publicado: (2021)

Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma
por: Swayden, Mirna, et al.
Publicado: (2020)

The reg4 Gene, Amplified in the Early Stages of Pancreatic Cancer Development, Is a Promising Therapeutic Target
por: Legoffic, Aude, et al.
Publicado: (2009)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
por: Bian, Benjamin, et al.
Publicado: (2019)

Gene expression profiling of tumours derived from ras(V12)/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development
por: Vasseur, Sophie, et al.
Publicado: (2005)

Editorial: Cancer Metabolism: Current Knowledge and Perspectives
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2019)

Pancreatitis-Associated Protein Does Not Predict Disease Relapse in Inflammatory Bowel Disease Patients
por: Nunes, Tiago, et al.
Publicado: (2014)

Isolated Pancreatic Metastasis from Malignant Melanoma: Is Pancreatectomy Worthwile?
por: Birnbaum, David Jérémie, et al.
Publicado: (2013)

Vitamin C Transporters in Cancer: Current Understanding and Gaps in Knowledge
por: Wohlrab, Christina, et al.
Publicado: (2017)

EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives
por: Sun, Keran, et al.
Publicado: (2020)

Knowledge mapping and current trends of Warburg effect in the field of cancer
por: Zhao, Quan, et al.
Publicado: (2023)

Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by ras(V12 )mutated protein and the E1A oncogene
por: Vasseur, Sophie, et al.
Publicado: (2003)

Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives
por: Pang, Zheng, et al.
Publicado: (2022)

Autophagy in Pancreatic Cancer
por: Grasso, Daniel, et al.
Publicado: (2012)

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis—a case control study
por: Claire, Decoster, et al.
Publicado: (2016)

Multidisciplinary team diagnosis and treatment of pancreatic cancer: Current landscape and future prospects
por: Yao, Weirong, et al.
Publicado: (2023)

Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
por: Huang, Can, et al.
Publicado: (2021)

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
por: Miyabayashi, Koji, et al.
Publicado: (2021)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
por: Li, Ying, et al.
Publicado: (2023)

Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings
por: Malcolm, James Alex, et al.
Publicado: (2023)

Stress Proteins and Pancreatic Cancer Metastasis
por: Cano, Carla E., et al.
Publicado: (2010)

Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer
por: Iovanna, Juan
Publicado: (2020)

Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects
por: Iovanna, Juan, et al.
Publicado: (2010)

The promise of epigenomic therapeutics in pancreatic cancer
por: Lomberk, Gwen A, et al.
Publicado: (2016)

Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective
por: Prisciandaro, Michele, et al.
Publicado: (2022)

Emerging current trends and research focus related to pancreatic cancer metabolism: A bibliometric and visualized analysis
por: Shen, Qian, et al.
Publicado: (2022)

Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
por: Cano, Carla E, et al.
Publicado: (2012)

Homotypic cell cannibalism, a cell‐death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
por: Cano, Carla E, et al.
Publicado: (2021)

IER3 in pancreatic carcinogenesis
por: Molejon, Maria Inés, et al.
Publicado: (2015)

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
por: Principe, Daniel R., et al.
Publicado: (2021)

Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Current Practice
por: Gemenetzis, Georgios, et al.
Publicado: (2021)

Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas
por: Sethi, Shenon, et al.
Publicado: (2021)

Extracellular Vesicle-Dependent Cross-Talk in Cancer—Focus on Pancreatic Cancer
por: Nannan, Lise, et al.
Publicado: (2020)

Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management
por: Liu, Ya, et al.
Publicado: (2021)

Current Trends and Research Hotspots in Pancreatic Stellate Cells: A Bibliometric Study
por: Yang, Zhaoming, et al.
Publicado: (2022)

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor
por: Gayet, Odile, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fogt5m6ee2njcj8c3ppvvhjn8r